我国药品流通领域存在的问题及对策研究

发布时间：2018-04-18 22:17

本文选题：药品流通 + 流通模式　；参考：《中国药房》2017年18期

【摘要】：目的:为我国药品流通领域改革提出政策建议。方法:梳理我国药品流通领域的现状,分析存在的问题及影响因素,并给出改革建议。结果与结论:我国药品流通行业处于快速发展和变革时期,各流通企业存在规模小、集中度低、费用率高、营利能力低、经营模式单一、缺乏核心竞争力和面临新型业态发展挑战等问题。大批医药企业目前仍然延续传统的产供销经营模式,对供应链管理缺乏全面、清晰的认识和了解,自身定位尚在摸索中,而医药电商自身发展机遇与挑战并存。药品流通业需要进行纵向和横向一体化整合,加快社会化"第三方"物流和医药电商的健康发展,并健全和完善适应新型业态健康发展的药品流通监管体系。
[Abstract]:Objective: to put forward some policy suggestions for the reform of drug circulation in China.Methods: the current situation of drug circulation in China was reviewed, the existing problems and influencing factors were analyzed, and the reform suggestions were given.Results & conclusion: the pharmaceutical circulation industry in China is in the period of rapid development and transformation. The circulation enterprises have small scale, low concentration, high cost rate, low profit ability and single management mode.Lack of core competitiveness and facing new business development challenges and other issues.At present, a large number of pharmaceutical enterprises still continue the traditional mode of production, supply and marketing management, lack of comprehensive, clear understanding and understanding of supply chain management, and their own positioning is still in the process of exploration, while the development opportunities and challenges of the pharmaceutical e-commerce enterprises coexist.It is necessary for the drug circulation industry to integrate vertically and horizontally, to accelerate the healthy development of socialized "third party" logistics and pharmaceutical e-commerce, and to perfect and perfect the supervision system of drug circulation which adapts to the healthy development of the new type of industry.
【作者单位】：中国医学科学院/北京协和医学院公共卫生学院;
【基金】：中央级公益性科研究院所基本项目国家卫生计生委药政司委托研究课题(No.药政[2016]9号)
【分类号】：R95

【参考文献】